Vasovasostomy and Vasoepididymostomy
No Results
No Results
processing….
Vasovasostomy (VV) and vasoepididymostomy (VE) are surgical procedures designed to bypass an obstruction in the male genital tract. These procedures are usually performed to restore fertility, although they are occasionally undertaken to relieve pain, such as in postvasectomy pain syndromes.
Vasovasostomy involves the anastomosis of segments of the vas deferens above and below an obstruction. The vast majority of vasovasostomies are performed to reverse a prior vasectomy, but the procedure is occasionally indicated for repair of an iatrogenic vasal injury secondary to prior surgery (eg, inguinal herniorrhaphy).
Vasoepididymostomy is a technically more demanding procedure than vasovasostomy. It involves anastomosis of the vas deferens to the epididymis in order to bypass an epididymal obstruction. This obstruction may be secondary to long-standing vasal obstruction resulting in damage to an epididymal tubule (epididymal blowout) or may result from epididymal infections or trauma
Surgical procedures to remove genital tract obstructions and to restore fertility have been attempted for almost 100 years. In 1903, Martin et al first reported a technique for vasoepididymostomy to treat an obstructed epididymis due to gonococcal infection. He described anastomosing the vas to a cut end of the epididymis using fine silver wires. This fistula technique of anastomosis remained the standard for nearly 75 years, until advances in technique and instrumentation made direct, single tubule anastomosis feasible.
In 1978, Silber first reported a technique for directly anastomosing the mucosa of the vas deferens to a single epididymal tubule. [1] While this required more technical skill and magnification than the fistula technique, it allowed precise alignment of the vasal and epididymal lumens, resulting in markedly improved fertility rates.
Quinby reported the first successful vasovasostomy for vasectomy reversal in 1919. The anastomosis was performed over a strand of silkworm gut that was later removed. By 1948, O’Conor reported a practice survey revealing that 18% of urologists had performed a vasal anastomosis procedure at least once and that the operation was successful in up to 40% of patients. [2] Various techniques have been tried since O’Conor’s survey, including the use of stents and adhesive materials to improve patency rates for the macroscopic anastomosis.
The next major advance occurred when Owen [3] and Silber [4] separately reported their techniques for microsurgical anastomosis in 1977. Silber reported patency rates of up to 94% using the 2-layer microsurgical technique for vasal anastomosis. This is the current gold standard for vasectomy reversal.
More recently, new literature has emerged investigating the use of robotic-assisted vasovasostomy with promising results. The handful of studies available, notably from Parekattil et al and Kavoussi, have found similar rates of patency compared with microsurgical technique. [5, 6] The potential benefits of the robotic technique vs the microsurgical approach appear to be decreased operative time, mildly increased patency rates, and decreased learning curve for the surgeon. Increased cost, as well as decreased magnification compared to the microsurgical technique are the main disadvantages. [7] It should be noted there is no current literature investigating the potential role of robotic-assisted VE, and therefore the robotic technique is limited to VV for the time being.
Azoospermia (the absence of sperm in the ejaculate) can result from an obstructed genital tract or a failure of spermatogenesis in the testicle. Vasovasostomies are indicated for an obstruction at the level of the vas deferens, while vasoepididymostomies are used to treat epididymal obstructions. The site of obstruction can often be discerned by examination of the fluid from the vasal end or from the epididymal tubule, as described below. The goal of both procedures is to restore genital tract patency and ultimately to allow conception. These procedures are not indicated for nonobstructive causes of azoospermia.
Vasectomy remains one of the most commonly performed operations in the United States and throughout the world. Despite careful preoperative counseling, between 3-6% of the men who undergo vasectomy ultimately desire a vasectomy reversal (VR). Restoring fertility and relief from postvasectomy pain syndrome (PVSP) have been cited as the top reasons for a reversal. [7]
Primary genital tract obstruction occurs in 7.4% of infertile males who have not undergone a prior vasectomy. While the cause may be multifactorial (eg, including epididymal trauma, infection, congenital hypoplasia of the ductal system), a significant number of these patients are candidates for vasoepididymostomy for restoration of the patency of the seminal tract.
Causes of vasal and epididymal obstruction are outlined in Table 1 (see image below). Vasal obstruction is usually the result of an intentional division for sterilization, although it occasionally may be caused by iatrogenic injury during surgical procedures (eg, herniorrhaphies).
An epididymal obstruction can be congenital or can result from an epididymal infection, trauma, or prior vasectomy. Congenital epididymal obstruction may occur in conjunction with atresia of the vas deferens, rendering surgical reconstruction impossible. This is usually associated with a cystic fibrosis genetic mutation, and these men may have no other phenotypic manifestations of cystic fibrosis. Some of these patients have a normal vas deferens and dysjunction of the vas deferens with the epididymis, and they may benefit from vasoepididymostomy.
Inflammatory obstruction of the epididymis can result from bacterial epididymitis. Neisseria gonorrhoeae usually affects only the distal epididymis, allowing a surgical bypass of the vas to the more proximal epididymis using a vasoepididymostomy.
Trauma to the epididymis is a relatively uncommon cause of an epididymal obstruction but may result from epididymal injury during scrotal surgeries (eg, spermatocelectomy, hydrocelectomy, testis biopsy).
An epididymal obstruction following vasectomy is the most likely cause of an epididymal obstruction. The buildup of high intraluminal pressures within the epididymis after a vasectomy can result in rupture of the delicate epididymal tubule, resulting in obstruction (eg, epididymal blowout). This phenomenon is more common in men who desire a reversal more than 10 years after their vasectomy and in patients in whom vasovasostomy has previously failed.
Patients who desire vasovasostomy for vasectomy reversal self-refer for evaluation. All other patients present for an evaluation of infertility after a trial of unprotected intercourse. A careful physical examination suggests the diagnosis of vasal or epididymal obstruction that is amenable to a vasovasostomy or vasoepididymostomy, respectively. Men with a genital tract obstruction have testes of normal size (>20 mL volume or 4 cm length) and consistency. The epididymis feels prominent proximal to a site of obstruction and feels flat (empty) distal to an obstructed tubule. Dilatation of the entire epididymis suggests an obstruction at either the junction of the epididymis with the vas deferens or within the vas deferens itself.
The indications for a vasovasostomy include vasectomy reversal and relief of postvasectomy pain syndrome. The latter indication is uncommon and remains of controversial efficacy. Prior to undertaking a vasovasostomy for vasectomy reversal, the female partner should be evaluated by a gynecologist to exclude concurrent female causes of infertility. A vasoepididymostomy is performed for the treatment of a genital tract obstruction at the level of the epididymis.
Both vasal and epididymal obstruction are suggested by azoospermia in the presence of a normal semen volume. Low-volume azoospermia (< 1.5 mL) is more suggestive of ejaculatory duct obstruction than vasal or epididymal obstruction. Patients must have active sperm production in the testes to be considered a candidate for a vasoepididymostomy. For this reason, a testis biopsy is usually performed at the time of or prior to planned reconstruction to document active spermatogenesis. The authors prefer to conduct a biopsy at the time of reconstruction, as this avoids the inevitable scarring that can further complicate reconstruction at a later date.
To understand the surgical bypass procedures needed to restore sperm flow, it is important to understand the basic anatomy and physiology of the seminal tract. Sperm is produced and then released into the seminiferous tubules. The sperm transits through the rete testis, efferent ductules, and into the epididymal tubule. See image below.
The epididymis consists of a single, highly convoluted tubule that is covered with tunica vaginalis. By convention, the epididymis is divided into the following anatomic segments: (1) the caput (head), (2) the corpora (body), and (3) the cauda (tail).
The proximal epididymis is involved in sperm maturation, whereas the distal region is the area of sperm storage. Vasoepididymal anastomosis to the more proximal epididymal tubule results in lower pregnancy rates because this bypasses a region of vital importance for sperm development.
At the terminal end of the epididymis, a thick muscle wall that forms the proximal end of the vas deferens surrounds the tubule. The vas deferens follows the spermatic cord, courses through the inguinal canal, and enters the pelvis via the internal inguinal ring. From the pelvis, the vas travels behind the bladder and joins with the ipsilateral seminal vesicle to form an ejaculatory duct, which enters the prostate posteriorly. Contraction of the muscular wall of the vas deferens serves to propel sperm from the epididymis into the prostatic urethra via the ejaculatory ducts.
For more information about the relevant anatomy, see Male Reproductive Organ Anatomy and Ductus Deferens (Vas Deferens) and Ejaculatory Duct Anatomy.
Silber SJ. Microscopic vasoepididymostomy: specific microanastomosis to the epididymal tubule. Fertil Steril. 1978 Nov. 30(5):565-71. [Medline].
O’Conor VJ. Anastomosis of vas deferens after purposeful division for sterility. J Am Med Assoc. 1948 Jan 17. 136(3):162. [Medline].
Owen ER. Microsurgical vasovasostomy: a reliable vasectomy reversal. Aust N Z J Surg. 1977 Jun. 47(3):305-9. [Medline].
Silber SJ. Perfect anatomical reconstruction of vas deferens with a new microscopic surgical technique. Fertil Steril. 1977 Jan. 28(1):72-7. [Medline].
Parekattil SJ, Gudeloglu A, Brahmbhatt J, Wharton J, Priola KB. Robotic assisted versus pure microsurgical vasectomy reversal: technique and prospective database controle trial. J Reconstr Microsurg. 2012. 28:435-44.
Kavoussi PK. Validation of robot-assisted vasectomy reversal. Asian J Androl. 2015. 17:245-7.
Abhishek P Patel, Ryan P Smith. Vasectomy Reversal: a clinical update. Asian Journal of Andrology. 1 March 2016. 18:365-371.
Lipshultz LI, Rumohr JA, Bennett RC. Techniques for Vasectomy Reversal. Urol Clin N Am. 2009. 36:375-82.
Wood S, Montazeri N, Sajjad Y, Troup S, Kingsland CR, et al. Current practice in the management of vasectomy reversal and unobstructive azoospermia in Merseyside and North Wales: a questionnaire-based survey. BJU Int. 2003. 91:839-44.
Silber SJ. Pregnancy after vasovasostomy for vasectomy reversal: a study of factors affecting long-term return of fertility in 282 patients followed for 10 years. Hum Reprod 1989. 1989. 4:318-22.
Dohle GR, Smith M. Microsurgical vasovasostomy at the Erasmus MC, 1998-2002: results and predictive factors. Ned Tijdschr Geneeskd. 2005. 149:2743-7.
Magheli A, Rais-Bahrami S, Kempkensteflfen C, Weiske WH, Miller K, et al. Impact obstructive interval and sperm granuloma on potency and pregnancy after vasectomy reversal. Int J Androl. 2010. 33:730-5.
Fuchs EF, Burt RA. Vasectomy reversal performed 15 years or more after vasectomy: correlation of pregnancy outcome with partner age and with pregnancy results of in vitro fertilization with intracytoplasmic sperm injection. Fertil Steril. 2002. 77:516-9.
Gerrard ER Jr., Sandlow JI, Oster RA, Burns JR, Box LC, et al. Effect of female partner age on pregnancy rates after vasectomy reversal. Fertil Steril. 2007. 87:1340-4.
Dewire DM, Thomas AJ. Microsurgical end-to-side vasoepididymostomy. Goldstein M, ed. Surgery of Male Infertility. Philadelphia, Pa: WB Saunders Co; 1995. 128-34.
Belker AM, Thomas AJ Jr, Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol. 1991 Mar. 145(3):505-11. [Medline].
Grober ED, Karpman E, Fanipour M. Vasectomy reversal outcomes among patients with vasal obstructive intervals greater than 10 years. Urology. 2014 Feb. 83 (2):320-3. [Medline].
Scovell JM, Mata DA, Ramasamy R, Herrel LA, Hsiao W, Lipshultz LI. Association between the presence of sperm in the vasal fluid during vasectomy reversal and postoperative patency: a systematic review and meta-analysis. Urology. 2015 Apr. 85 (4):809-13. [Medline].
Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992 Jul 4. 340(8810):17-8. [Medline].
Kolettis PN, Thomas AJ Jr. Vasoepididymostomy for vasectomy reversal: a critical assessment in the era of intracytoplasmic sperm injection. J Urol. 1997 Aug. 158(2):467-70. [Medline].
Berardinucci D, Zini A, Jarvi K. Outcome of microsurgical reconstruction in men with suspected epididymal obstruction. J Urol. 1998 Mar. 159(3):831-4. [Medline].
Boorjian S, Lipkin M, Goldstein M. The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversal. J Urol. 2004 Jan. 171(1):304-6. [Medline].
Fogdestam I, Fall M, Nilsson S. Microsurgical epididymovasostomy in the treatment of occlusive azoospermia. Fertil Steril. 1986 Nov. 46(5):925-9. [Medline].
Hernandez J, Sabanegh ES. Repeat vasectomy reversal after initial failure: overall results and predictors for success. J Urol. 1999 Apr. 161(4):1153-6. [Medline].
Kolettis PN. Restructuring reconstructive techniques–advances in reconstructive techniques. Urol Clin North Am. 2008 May. 35(2):229-34, viii-ix. [Medline].
Marmar JL. Management of the epididymal tubule during an end-to-side vasoepididymostomy. J Urol. 1995 Jul. 154(1):93-6. [Medline].
Martin E, Carnett JB, Levi JV. The surgical treatment of sterility due to obstruction at the epididymis. Together with a study of the morphology of human spermatozoa. Medical Bulletin: University of Pennsylvania. 1903. 15:2.
Meng MV, Greene KL, Turek PJ. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J Urol. 2005 Nov. 174(5):1926-31; discussion 1931. [Medline].
Parekattil SJ, Kuang W, Agarwal A, Thomas AJ. Model to predict if a vasoepididymostomy will be required for vasectomy reversal. J Urol. 2005 May. 173(5):1681-4. [Medline].
Patel SR, Sigman M. Comparison of outcomes of vasovasostomy performed in the convoluted and straight vas deferens. J Urol. 2008 Jan. 179(1):256-9. [Medline].
Pierpaoli S, Mulhall JP. Vasectomy reversal in the age of intracytoplasmic sperm injection. Curr Opin Urol. 1998 Nov. 8(6):531-4. [Medline].
Shin D, Chuang WW, Lipshultz LI. Vasovasostomy. BJU Int. 2004 Jun. 93(9):1363-78. [Medline].
Sigman M. The relationship between intravasal sperm quality and patency rates after vasovasostomy. J Urol. 2004 Jan. 171(1):307-9. [Medline].
Silber SJ. Epididymal extravasation following vasectomy as a cause for failure of vasectomy reversal. Fertil Steril. 1979 Mar. 31(3):309-15. [Medline].
Thomas AJ. Vasoepididymostomy. Thomas AJ, Nagler HM, eds. Atlas of Surgical Management of Male Infertility. New York: Igaku-Shoin; 1995. 62-70.
Thomas AJ Jr. Vasoepididymostomy. Urol Clin North Am. 1987 Aug. 14(3):527-38. [Medline].
Vasectomy reversal. Fertil Steril. 2006 Nov. 86(5 Suppl):S268-71. [Medline].
Jacob C Parke, MD Resident Physician, Department of Urology, William Beaumont Hospital
Jacob C Parke, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.
Chirag N Dave, MD Faculty in Urology, Fellow in Male Infertility and Genitourinary Reconstruction, The James Buchanan Brady Urological Institute and Urology Department, Johns Hopkins University School of Medicine
Chirag N Dave, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Physicians, American Urological Association
Disclosure: Nothing to disclose.
Richard C Bennett, MD Assistant Professor of Urology, Oakland University William Beaumont School of Medicine; Urologist, Comprehensive Urology
Richard C Bennett, MD is a member of the following medical societies: American Society for Reproductive Medicine, American Urological Association, Michigan State Medical Society, Sexual Medicine Society of North America
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Edward David Kim, MD, FACS Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, Sexual Medicine Society of North America, Tennessee Medical Association
Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Endo, Avadel.
Edmund S Sabanegh, Jr, MD Chairman, Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation
Edmund S Sabanegh, Jr, MD is a member of the following medical societies: American Medical Association, American Society of Andrology, Society of Reproductive Surgeons, Society for the Study of Male Reproduction, American Society for Reproductive Medicine, American Urological Association, SWOG
Disclosure: Nothing to disclose.
Mary K Samplaski, MD Resident Physician, Glickman Urologic and Kidney Institute, Cleveland Clinic Foundation
Mary K Samplaski, MD is a member of the following medical societies: American Medical Association, American Urological Association
Disclosure: Nothing to disclose.
Yagil Barazani, MD Associate Physician, Department of Urology, The Permanente Medical Group
Disclosure: Nothing to disclose.
Medscape Reference thanks Dennis G Lusaya, MD, Associate Professor II, Department of Surgery (Urology), University of Santo Tomas; Head of Urology Unit, Benavides Cancer Institute, University of Santo Tomas Hospital; Chief of Urologic Oncology, St Luke’s Medical Center Global City, Philippines, for the video contribution to this article.
Medscape Reference also thanks Edgar V Lerma, MD, FACP, FASN, FAHA, Clinical Associate Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Research Director, Internal Medicine Training Program, Advocate Christ Medical Center; Consulting Staff, Associates in Nephrology, SC, for his assistance with the video contribution to this article.
Vasovasostomy and Vasoepididymostomy
Research & References of Vasovasostomy and Vasoepididymostomy|A&C Accounting And Tax Services
Source
0 Comments